Industry Research Reports

Home > Reports > Pharma & Healthcare > New Drug for Alzheimer's Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

New Drug for Alzheimer's Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-07-17

Pages: 107 Pages

Report ld: 3244477

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for New Drug for Alzheimer's Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for New Drug for Alzheimer's Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for New Drug for Alzheimer's Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for New Drug for Alzheimer's Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of New Drug for Alzheimer's Treatment include Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for New Drug for Alzheimer's Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of New Drug for Alzheimer's Treatment by region & country, by Type, and by Application.

The New Drug for Alzheimer's Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Drug for Alzheimer's Treatment.

Market Segmentation

Report Metric
Details
Report Title
New Drug for Alzheimer's Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global New Drug for Alzheimer's Treatment Companies Covered
Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson
Global New Drug for Alzheimer's Treatment Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global New Drug for Alzheimer's Treatment Market, Segment by Type
AChE Target

Aβ Target

BChE Target

Others
Global New Drug for Alzheimer's Treatment Market, Segment by Application
Preclinical Stage

Mild Cognitive Impairment Stage

Dementia Stage
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of New Drug for Alzheimer's Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of New Drug for Alzheimer's Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of New Drug for Alzheimer's Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 New Drug for Alzheimer's Treatment Product Introduction
    1.2 Global New Drug for Alzheimer's Treatment Market Size Forecast
        1.2.1 Global New Drug for Alzheimer's Treatment Sales Value (2019-2030)
        1.2.2 Global New Drug for Alzheimer's Treatment Sales Volume (2019-2030)
        1.2.3 Global New Drug for Alzheimer's Treatment Sales Price (2019-2030)
    1.3 New Drug for Alzheimer's Treatment Market Trends & Drivers
        1.3.1 New Drug for Alzheimer's Treatment Industry Trends
        1.3.2 New Drug for Alzheimer's Treatment Market Drivers & Opportunity
        1.3.3 New Drug for Alzheimer's Treatment Market Challenges
        1.3.4 New Drug for Alzheimer's Treatment Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global New Drug for Alzheimer's Treatment Players Revenue Ranking (2023)
    2.2 Global New Drug for Alzheimer's Treatment Revenue by Company (2019-2024)
    2.3 Global New Drug for Alzheimer's Treatment Players Sales Volume Ranking (2023)
    2.4 Global New Drug for Alzheimer's Treatment Sales Volume by Company Players (2019-2024)
    2.5 Global New Drug for Alzheimer's Treatment Average Price by Company (2019-2024)
    2.6 Key Manufacturers New Drug for Alzheimer's Treatment Manufacturing Base and Headquarters
    2.7 Key Manufacturers New Drug for Alzheimer's Treatment Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of New Drug for Alzheimer's Treatment
    2.9 New Drug for Alzheimer's Treatment Market Competitive Analysis
        2.9.1 New Drug for Alzheimer's Treatment Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by New Drug for Alzheimer's Treatment Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug for Alzheimer's Treatment as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 AChE Target
        3.1.2 Aβ Target
        3.1.3 BChE Target
        3.1.4 Others
    3.2 Global New Drug for Alzheimer's Treatment Sales Value by Type
        3.2.1 Global New Drug for Alzheimer's Treatment Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global New Drug for Alzheimer's Treatment Sales Value, by Type (2019-2030)
        3.2.3 Global New Drug for Alzheimer's Treatment Sales Value, by Type (%) (2019-2030)
    3.3 Global New Drug for Alzheimer's Treatment Sales Volume by Type
        3.3.1 Global New Drug for Alzheimer's Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global New Drug for Alzheimer's Treatment Sales Volume, by Type (2019-2030)
        3.3.3 Global New Drug for Alzheimer's Treatment Sales Volume, by Type (%) (2019-2030)
    3.4 Global New Drug for Alzheimer's Treatment Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Preclinical Stage
        4.1.2 Mild Cognitive Impairment Stage
        4.1.3 Dementia Stage
    4.2 Global New Drug for Alzheimer's Treatment Sales Value by Application
        4.2.1 Global New Drug for Alzheimer's Treatment Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global New Drug for Alzheimer's Treatment Sales Value, by Application (2019-2030)
        4.2.3 Global New Drug for Alzheimer's Treatment Sales Value, by Application (%) (2019-2030)
    4.3 Global New Drug for Alzheimer's Treatment Sales Volume by Application
        4.3.1 Global New Drug for Alzheimer's Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global New Drug for Alzheimer's Treatment Sales Volume, by Application (2019-2030)
        4.3.3 Global New Drug for Alzheimer's Treatment Sales Volume, by Application (%) (2019-2030)
    4.4 Global New Drug for Alzheimer's Treatment Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global New Drug for Alzheimer's Treatment Sales Value by Region
        5.1.1 Global New Drug for Alzheimer's Treatment Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global New Drug for Alzheimer's Treatment Sales Value by Region (2019-2024)
        5.1.3 Global New Drug for Alzheimer's Treatment Sales Value by Region (2025-2030)
        5.1.4 Global New Drug for Alzheimer's Treatment Sales Value by Region (%), (2019-2030)
    5.2 Global New Drug for Alzheimer's Treatment Sales Volume by Region
        5.2.1 Global New Drug for Alzheimer's Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global New Drug for Alzheimer's Treatment Sales Volume by Region (2019-2024)
        5.2.3 Global New Drug for Alzheimer's Treatment Sales Volume by Region (2025-2030)
        5.2.4 Global New Drug for Alzheimer's Treatment Sales Volume by Region (%), (2019-2030)
    5.3 Global New Drug for Alzheimer's Treatment Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        5.4.2 North America New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        5.5.2 Europe New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        5.6.2 Asia Pacific New Drug for Alzheimer's Treatment Sales Value by Region (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        5.7.2 South America New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        5.8.2 Middle East & Africa New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions New Drug for Alzheimer's Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions New Drug for Alzheimer's Treatment Sales Value
        6.2.1 Key Countries/Regions New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.2.2 Key Countries/Regions New Drug for Alzheimer's Treatment Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.3.2 United States New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States New Drug for Alzheimer's Treatment Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.4.2 Europe New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe New Drug for Alzheimer's Treatment Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.5.2 China New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
        6.5.3 China New Drug for Alzheimer's Treatment Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.6.2 Japan New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan New Drug for Alzheimer's Treatment Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.7.2 South Korea New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea New Drug for Alzheimer's Treatment Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.8.2 Southeast Asia New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia New Drug for Alzheimer's Treatment Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India New Drug for Alzheimer's Treatment Sales Value, 2019-2030
        6.9.2 India New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
        6.9.3 India New Drug for Alzheimer's Treatment Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Biogen
        7.1.1 Biogen Company Information
        7.1.2 Biogen Introduction and Business Overview
        7.1.3 Biogen New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.1.4 Biogen New Drug for Alzheimer's Treatment Product Offerings
        7.1.5 Biogen Recent Development
    7.2 Eisai
        7.2.1 Eisai Company Information
        7.2.2 Eisai Introduction and Business Overview
        7.2.3 Eisai New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.2.4 Eisai New Drug for Alzheimer's Treatment Product Offerings
        7.2.5 Eisai Recent Development
    7.3 Eli Lilly
        7.3.1 Eli Lilly Company Information
        7.3.2 Eli Lilly Introduction and Business Overview
        7.3.3 Eli Lilly New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.3.4 Eli Lilly New Drug for Alzheimer's Treatment Product Offerings
        7.3.5 Eli Lilly Recent Development
    7.4 Neurimmune
        7.4.1 Neurimmune Company Information
        7.4.2 Neurimmune Introduction and Business Overview
        7.4.3 Neurimmune New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.4.4 Neurimmune New Drug for Alzheimer's Treatment Product Offerings
        7.4.5 Neurimmune Recent Development
    7.5 Roche
        7.5.1 Roche Company Information
        7.5.2 Roche Introduction and Business Overview
        7.5.3 Roche New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.5.4 Roche New Drug for Alzheimer's Treatment Product Offerings
        7.5.5 Roche Recent Development
    7.6 AstraZeneca
        7.6.1 AstraZeneca Company Information
        7.6.2 AstraZeneca Introduction and Business Overview
        7.6.3 AstraZeneca New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.6.4 AstraZeneca New Drug for Alzheimer's Treatment Product Offerings
        7.6.5 AstraZeneca Recent Development
    7.7 Green Valley
        7.7.1 Green Valley Company Information
        7.7.2 Green Valley Introduction and Business Overview
        7.7.3 Green Valley New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.7.4 Green Valley New Drug for Alzheimer's Treatment Product Offerings
        7.7.5 Green Valley Recent Development
    7.8 Vivoryon
        7.8.1 Vivoryon Company Information
        7.8.2 Vivoryon Introduction and Business Overview
        7.8.3 Vivoryon New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.8.4 Vivoryon New Drug for Alzheimer's Treatment Product Offerings
        7.8.5 Vivoryon Recent Development
    7.9 Simcere
        7.9.1 Simcere Company Information
        7.9.2 Simcere Introduction and Business Overview
        7.9.3 Simcere New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.9.4 Simcere New Drug for Alzheimer's Treatment Product Offerings
        7.9.5 Simcere Recent Development
    7.10 Johnson and Johnson
        7.10.1 Johnson and Johnson Company Information
        7.10.2 Johnson and Johnson Introduction and Business Overview
        7.10.3 Johnson and Johnson New Drug for Alzheimer's Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
        7.10.4 Johnson and Johnson New Drug for Alzheimer's Treatment Product Offerings
        7.10.5 Johnson and Johnson Recent Development

 8 Industry Chain Analysis
    8.1 New Drug for Alzheimer's Treatment Industrial Chain
    8.2 New Drug for Alzheimer's Treatment Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 New Drug for Alzheimer's Treatment Sales Model
        8.5.2 Sales Channel
        8.5.3 New Drug for Alzheimer's Treatment Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. New Drug for Alzheimer's Treatment Market Trends
 Table 2. New Drug for Alzheimer's Treatment Market Drivers & Opportunity
 Table 3. New Drug for Alzheimer's Treatment Market Challenges
 Table 4. New Drug for Alzheimer's Treatment Market Restraints
 Table 5. Global New Drug for Alzheimer's Treatment Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global New Drug for Alzheimer's Treatment Revenue Market Share by Company (2019-2024)
 Table 7. Global New Drug for Alzheimer's Treatment Sales Volume by Company (2019-2024) & (K Dose)
 Table 8. Global New Drug for Alzheimer's Treatment Sales Volume Market Share by Company (2019-2024)
 Table 9. Global Market New Drug for Alzheimer's Treatment Price by Company (2019-2024) & (US$/Dose)
 Table 10. Key Manufacturers New Drug for Alzheimer's Treatment Manufacturing Base and Headquarters
 Table 11. Key Manufacturers New Drug for Alzheimer's Treatment Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of New Drug for Alzheimer's Treatment
 Table 13. Global New Drug for Alzheimer's Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug for Alzheimer's Treatment as of 2023)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global New Drug for Alzheimer's Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 17. Global New Drug for Alzheimer's Treatment Sales Value by Type (2019-2024) & (US$ Million)
 Table 18. Global New Drug for Alzheimer's Treatment Sales Value by Type (2025-2030) & (US$ Million)
 Table 19. Global New Drug for Alzheimer's Treatment Sales Market Share in Value by Type (2019-2024)
 Table 20. Global New Drug for Alzheimer's Treatment Sales Market Share in Value by Type (2025-2030)
 Table 21. Global New Drug for Alzheimer's Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Dose)
 Table 22. Global New Drug for Alzheimer's Treatment Sales Volume by Type (2019-2024) & (K Dose)
 Table 23. Global New Drug for Alzheimer's Treatment Sales Volume by Type (2025-2030) & (K Dose)
 Table 24. Global New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2019-2024)
 Table 25. Global New Drug for Alzheimer's Treatment Sales Market Share in Volume by Type (2025-2030)
 Table 26. Global New Drug for Alzheimer's Treatment Price by Type (2019-2024) & (US$/Dose)
 Table 27. Global New Drug for Alzheimer's Treatment Price by Type (2025-2030) & (US$/Dose)
 Table 28. Global New Drug for Alzheimer's Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 29. Global New Drug for Alzheimer's Treatment Sales Value by Application (2019-2024) & (US$ Million)
 Table 30. Global New Drug for Alzheimer's Treatment Sales Value by Application (2025-2030) & (US$ Million)
 Table 31. Global New Drug for Alzheimer's Treatment Sales Market Share in Value by Application (2019-2024)
 Table 32. Global New Drug for Alzheimer's Treatment Sales Market Share in Value by Application (2025-2030)
 Table 33. Global New Drug for Alzheimer's Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Dose)
 Table 34. Global New Drug for Alzheimer's Treatment Sales Volume by Application (2019-2024) & (K Dose)
 Table 35. Global New Drug for Alzheimer's Treatment Sales Volume by Application (2025-2030) & (K Dose)
 Table 36. Global New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2019-2024)
 Table 37. Global New Drug for Alzheimer's Treatment Sales Market Share in Volume by Application (2025-2030)
 Table 38. Global New Drug for Alzheimer's Treatment Price by Application (2019-2024) & (US$/Dose)
 Table 39. Global New Drug for Alzheimer's Treatment Price by Application (2025-2030) & (US$/Dose)
 Table 40. Global New Drug for Alzheimer's Treatment Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 41. Global New Drug for Alzheimer's Treatment Sales Value by Region (2019-2024) & (US$ Million)
 Table 42. Global New Drug for Alzheimer's Treatment Sales Value by Region (2025-2030) & (US$ Million)
 Table 43. Global New Drug for Alzheimer's Treatment Sales Value by Region (2019-2024) & (%)
 Table 44. Global New Drug for Alzheimer's Treatment Sales Value by Region (2025-2030) & (%)
 Table 45. Global New Drug for Alzheimer's Treatment Sales Volume by Region (K Dose): 2019 VS 2023 VS 2030
 Table 46. Global New Drug for Alzheimer's Treatment Sales Volume by Region (2019-2024) & (K Dose)
 Table 47. Global New Drug for Alzheimer's Treatment Sales Volume by Region (2025-2030) & (K Dose)
 Table 48. Global New Drug for Alzheimer's Treatment Sales Volume by Region (2019-2024) & (%)
 Table 49. Global New Drug for Alzheimer's Treatment Sales Volume by Region (2025-2030) & (%)
 Table 50. Global New Drug for Alzheimer's Treatment Average Price by Region (2019-2024) & (US$/Dose)
 Table 51. Global New Drug for Alzheimer's Treatment Average Price by Region (2025-2030) & (US$/Dose)
 Table 52. Key Countries/Regions New Drug for Alzheimer's Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 53. Key Countries/Regions New Drug for Alzheimer's Treatment Sales Value, (2019-2024) & (US$ Million)
 Table 54. Key Countries/Regions New Drug for Alzheimer's Treatment Sales Value, (2025-2030) & (US$ Million)
 Table 55. Key Countries/Regions New Drug for Alzheimer's Treatment Sales Volume, (2019-2024) & (K Dose)
 Table 56. Key Countries/Regions New Drug for Alzheimer's Treatment Sales Volume, (2025-2030) & (K Dose)
 Table 57. Biogen Company Information
 Table 58. Biogen Introduction and Business Overview
 Table 59. Biogen New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 60. Biogen New Drug for Alzheimer's Treatment Product Offerings
 Table 61. Biogen Recent Development
 Table 62. Eisai Company Information
 Table 63. Eisai Introduction and Business Overview
 Table 64. Eisai New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 65. Eisai New Drug for Alzheimer's Treatment Product Offerings
 Table 66. Eisai Recent Development
 Table 67. Eli Lilly Company Information
 Table 68. Eli Lilly Introduction and Business Overview
 Table 69. Eli Lilly New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 70. Eli Lilly New Drug for Alzheimer's Treatment Product Offerings
 Table 71. Eli Lilly Recent Development
 Table 72. Neurimmune Company Information
 Table 73. Neurimmune Introduction and Business Overview
 Table 74. Neurimmune New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 75. Neurimmune New Drug for Alzheimer's Treatment Product Offerings
 Table 76. Neurimmune Recent Development
 Table 77. Roche Company Information
 Table 78. Roche Introduction and Business Overview
 Table 79. Roche New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 80. Roche New Drug for Alzheimer's Treatment Product Offerings
 Table 81. Roche Recent Development
 Table 82. AstraZeneca Company Information
 Table 83. AstraZeneca Introduction and Business Overview
 Table 84. AstraZeneca New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 85. AstraZeneca New Drug for Alzheimer's Treatment Product Offerings
 Table 86. AstraZeneca Recent Development
 Table 87. Green Valley Company Information
 Table 88. Green Valley Introduction and Business Overview
 Table 89. Green Valley New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 90. Green Valley New Drug for Alzheimer's Treatment Product Offerings
 Table 91. Green Valley Recent Development
 Table 92. Vivoryon Company Information
 Table 93. Vivoryon Introduction and Business Overview
 Table 94. Vivoryon New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 95. Vivoryon New Drug for Alzheimer's Treatment Product Offerings
 Table 96. Vivoryon Recent Development
 Table 97. Simcere Company Information
 Table 98. Simcere Introduction and Business Overview
 Table 99. Simcere New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 100. Simcere New Drug for Alzheimer's Treatment Product Offerings
 Table 101. Simcere Recent Development
 Table 102. Johnson and Johnson Company Information
 Table 103. Johnson and Johnson Introduction and Business Overview
 Table 104. Johnson and Johnson New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 105. Johnson and Johnson New Drug for Alzheimer's Treatment Product Offerings
 Table 106. Johnson and Johnson Recent Development
 Table 107. Key Raw Materials Lists
 Table 108. Raw Materials Key Suppliers Lists
 Table 109. New Drug for Alzheimer's Treatment Downstream Customers
 Table 110. New Drug for Alzheimer's Treatment Distributors List
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. New Drug for Alzheimer's Treatment Product Picture
 Figure 2. Global New Drug for Alzheimer's Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global New Drug for Alzheimer's Treatment Sales Value (2019-2030) & (US$ Million)
 Figure 4. Global New Drug for Alzheimer's Treatment Sales Volume (2019-2030) & (K Dose)
 Figure 5. Global New Drug for Alzheimer's Treatment Sales Price (2019-2030) & (US$/Dose)
 Figure 6. New Drug for Alzheimer's Treatment Report Years Considered
 Figure 7. Global New Drug for Alzheimer's Treatment Players Revenue Ranking (2023) & (US$ Million)
 Figure 8. Global New Drug for Alzheimer's Treatment Players Sales Volume Ranking (2023) & (US$ Million)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by New Drug for Alzheimer's Treatment Revenue in 2023
 Figure 10. New Drug for Alzheimer's Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 11. AChE Target Picture
 Figure 12. Aβ Target Picture
 Figure 13. BChE Target Picture
 Figure 14. Others Picture
 Figure 15. Global New Drug for Alzheimer's Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 16. Global New Drug for Alzheimer's Treatment Sales Value Market Share by Type, 2023 & 2030
 Figure 17. Global New Drug for Alzheimer's Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Dose)
 Figure 18. Global New Drug for Alzheimer's Treatment Sales Volume Market Share by Type, 2023 & 2030
 Figure 19. Global New Drug for Alzheimer's Treatment Price by Type (2019-2030) & (US$/Dose)
 Figure 20. Product Picture of Preclinical Stage
 Figure 21. Product Picture of Mild Cognitive Impairment Stage
 Figure 22. Product Picture of Dementia Stage
 Figure 23. Global New Drug for Alzheimer's Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 24. Global New Drug for Alzheimer's Treatment Sales Value Market Share by Application, 2023 & 2030
 Figure 25. Global New Drug for Alzheimer's Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Dose)
 Figure 26. Global New Drug for Alzheimer's Treatment Sales Volume Market Share by Application, 2023 & 2030
 Figure 27. Global New Drug for Alzheimer's Treatment Price by Application (2019-2030) & (US$/Dose)
 Figure 28. North America New Drug for Alzheimer's Treatment Sales Value (2019-2030) & (US$ Million)
 Figure 29. North America New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030
 Figure 30. Europe New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 31. Europe New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030
 Figure 32. Asia Pacific New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific New Drug for Alzheimer's Treatment Sales Value by Region (%), 2023 VS 2030
 Figure 34. South America New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 35. South America New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030
 Figure 36. Middle East & Africa New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 37. Middle East & Africa New Drug for Alzheimer's Treatment Sales Value by Country (%), 2023 VS 2030
 Figure 38. Key Countries/Regions New Drug for Alzheimer's Treatment Sales Value (%), (2019-2030)
 Figure 39. Key Countries/Regions New Drug for Alzheimer's Treatment Sales Volume (%), (2019-2030)
 Figure 40. United States New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 41. United States New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
 Figure 42. United States New Drug for Alzheimer's Treatment Sales Value by Application (%), 2023 VS 2030
 Figure 43. Europe New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 44. Europe New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
 Figure 45. Europe New Drug for Alzheimer's Treatment Sales Value by Application (%), 2023 VS 2030
 Figure 46. China New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 47. China New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
 Figure 48. China New Drug for Alzheimer's Treatment Sales Value by Application (%), 2023 VS 2030
 Figure 49. Japan New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 50. Japan New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
 Figure 51. Japan New Drug for Alzheimer's Treatment Sales Value by Application (%), 2023 VS 2030
 Figure 52. South Korea New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 53. South Korea New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
 Figure 54. South Korea New Drug for Alzheimer's Treatment Sales Value by Application (%), 2023 VS 2030
 Figure 55. Southeast Asia New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 56. Southeast Asia New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
 Figure 57. Southeast Asia New Drug for Alzheimer's Treatment Sales Value by Application (%), 2023 VS 2030
 Figure 58. India New Drug for Alzheimer's Treatment Sales Value, (2019-2030) & (US$ Million)
 Figure 59. India New Drug for Alzheimer's Treatment Sales Value by Type (%), 2023 VS 2030
 Figure 60. India New Drug for Alzheimer's Treatment Sales Value by Application (%), 2023 VS 2030
 Figure 61. New Drug for Alzheimer's Treatment Industrial Chain
 Figure 62. New Drug for Alzheimer's Treatment Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed

Description

The global market for New Drug for Alzheimer's Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for New Drug for Alzheimer's Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for New Drug for Alzheimer's Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for New Drug for Alzheimer's Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of New Drug for Alzheimer's Treatment include Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for New Drug for Alzheimer's Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of New Drug for Alzheimer's Treatment by region & country, by Type, and by Application.

The New Drug for Alzheimer's Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Drug for Alzheimer's Treatment.

Market Segmentation